Berti Giovanna Noronha, Garcia Igor Gutschov Oviedo, de Toledo João Pedro Ruas Floriano, Tatemoto Júlia Rodrigues, Marino Lais Watanabe, Legori Mariana de Medeiros, de Toledo Sérgio Floriano
Centro Universitário Lusíada SantosSP Brazil Centro Universitário Lusíada, Santos, SP, Brazil.
Rev Bras Ginecol Obstet. 2024 Dec 4;46. doi: 10.61622/rbgo/2024rbgo89. eCollection 2024.
The aim of this study is to assess the use of metformin with or without insulin for the treatment of Gestational Diabetes Mellitus compared to insulin alone.
This article consists of a systematic review of randomized clinical trials. The searches were carried out on MEDLINE including 7 studies, between 2010 to 2021.
Randomized clinical trials comparing metformin and insulin written in English, Spanish or Portuguese, with no time limit, were included.
Data was extracted from all the 7 articles and compared statistically when possible. Whenever data was not available or couldn't be statistically compared, the main results were described in detail.
Insulin alone is not superior than metformin with or without insulin on gestational diabetes mellitus.
There is a potential viability of using metformin as an alternative compared to insulin alone in the treatment of Gestational Diabetes Mellitus. However, all assessed outcomes have a very low level of certainty of evidence and more studies are necessary to support these findings.
本研究旨在评估与单独使用胰岛素相比,二甲双胍联合或不联合胰岛素治疗妊娠期糖尿病的效果。
本文包括对随机临床试验的系统评价。检索了MEDLINE数据库,纳入了2010年至2021年间的7项研究。
纳入了比较二甲双胍和胰岛素的随机临床试验,语言为英语、西班牙语或葡萄牙语,无时间限制。
从所有7篇文章中提取数据,并在可能的情况下进行统计学比较。当数据不可用或无法进行统计学比较时,详细描述主要结果。
单独使用胰岛素在治疗妊娠期糖尿病方面并不优于联合或不联合胰岛素使用的二甲双胍。
与单独使用胰岛素相比,二甲双胍作为妊娠期糖尿病治疗的替代药物具有潜在可行性。然而,所有评估结果的证据确定性水平都非常低,需要更多研究来支持这些发现。